Androgen replacement therapy improves function in male rat muscles independently of hypertrophy and activation of the Akt/mTOR pathway

Acta Physiologica

Volumn 195, Issue 4, 2009, Pages 471-482

  Hourde C ^a,b,c   Jagerschmidt, C ^d   Clement Lacroix P ^d   Vignaud, A ^a,b,c   Ammann, P ^e   Butler Browne, G S ^a,b,c   Ferry, A ^a,b,c,f,g  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Institut de Myologie   (France)

^d Galapagos   (France)

^e Division des Maladies Osseuses   (Switzerland)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g University of Medicine Pierre and Marie Curie   (France)

Author keywords

Ageing; Akt mTor signalling; Androgen; Force production; Hormone replacement therapy; Skeletal muscle

Indexed keywords

ANDROSTANOLONE; CITRATE SYNTHASE; MAMMALIAN TARGET OF RAPAMYCIN; MYOSIN HEAVY CHAIN; NANDROLONE DECANOATE; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN S6;

ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; CONTROLLED STUDY; MALE; MUSCLE ATROPHY; MUSCLE CONTRACTILITY; MUSCLE HYPERTROPHY; MUSCLE METABOLISM; MUSCLE WEAKNESS; NONHUMAN; ORCHIECTOMY; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SOLEUS MUSCLE; TIBIA;

ANABOLIC AGENTS; ANDROGENS; ANIMALS; BONE DENSITY; CITRATE (SI)-SYNTHASE; DIHYDROTESTOSTERONE; HORMONE REPLACEMENT THERAPY; HYPERTROPHY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOSIN HEAVY CHAINS; NANDROLONE; ONCOGENE PROTEIN V-AKT; ORCHIECTOMY; PROTEIN-SERINE-THREONINE KINASES; RATS; TIBIA;

EID: 61849120350     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2008.01902.x     Document Type: Article

References (28)

1. Axell, A.M., MacLean, H.E., Plant, D.R., Harcourt, L.J., Davis, J.A., Jimenez, M., Handelsman, D.J., Lynch, G.S. Zajac, J.D. 2006. Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice. Am J Physiol Endocrinol Metab 291, E506 E516.
2. Bhasin, S., Woodhouse, L. Storer, T.W. 2001. Proof of the effect of testosterone on skeletal muscle. J Endocrinol 170, 27 38.
3. Borst, S.E. Conover, C.F. 2006. Orchiectomized Fischer 344 male rat models body composition in hypogonadal state. Life Sci 79, 411 415.
4. Borst, S.E., Conover, C.F., Carter, C.S., Gregory, C.M., Marzetti, E., Leeuwenburgh, C., Vandenborne, K. Wronski, T.J. 2007. Anabolic effects of testosterone are preserved during inhibition of 5alpha-reductase. Am J Physiol Endocrinol Metab 293, E507 E514.
5. Brown, M., Fisher, J.S. Hasser, E.M. 2001. Gonadectomy and reduced physical activity: effects on skeletal muscle. Arch Phys Med Rehabil 82, 93 97.
6. Degens, H. Veerkamp, J.H. 1994. Changes in oxidative capacity and fatigue resistance in skeletal muscle. Int J Biochem 26, 871 878.
7. Deldicque, L., Theisen, D. Francaux, M. 2005. Regulation of mTOR by amino acids and resistance exercise in skeletal muscle. Eur J Appl Physiol 94, 1 10.
8. Gao, W., Reiser, P.J., Coss, C.C., Phelps, M.A., Kearbey, J.D., Miller, D.D. Dalton, J.T. 2005. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. Endocrinology 146, 4887 4897.
9. Hanada, K., Furuya, K., Yamamoto, N., Nejishima, H., Ichikawa, K., Nakamura, T., Miyakawa, M., Amano, S., Sumita, Y. Oguro, N. 2003. Bone anabolic effects of S-40503, a novel nonsteroidal selective androgen receptor modulator (SARM), in rat models of osteoporosis. Biol Pharm Bull 26, 1563 1569.
10. + pumps: implications for contractility. Am J Physiol 274, R864 R867.
11. Johansson, C., Lannergren, J., Lunde, P.K., Vennstrom, B., Thoren, P. Westerblad, H. 2000. Isometric force and endurance in soleus muscle of thyroid hormone receptor-alpha(1)- or -beta-deficient mice. Am J Physiol Regul Integr Comp Physiol 278, R598 R603.
12. Joumaa, W.H., Bouhlel, A. Leoty, C. 2002. Post-effects of nandrolone decanoate treatment on contractile responses of rat skeletal muscles. Jpn J Physiol 52, 479 487.
13. Kline, W.O., Panaro, F.J., Yang, H. Bodine, S.C. 2007. Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. J Appl Physiol 102, 740 747.
14. Liu, P.Y., Swerdloff, R.S. Veldhuis, J.D. 2004. Clinical review 171: the rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 89, 4789 4796.
15. Mekraldi, S., Toromanoff, A., Rizzoli, R. Ammann, P. 2005. Pamidronate prevents bone loss and decreased bone strength in adult female and male rats fed an isocaloric low-protein diet. J Bone Miner Res 20, 1365 1371.
16. Miner, J.N., Chang, W., Chapman, M.S., Finn, P.D., Hong, M.H., Lopez, F.J., Marschke, K.B., Rosen, J., Schrader, W., Turner, R., van Oeveren, A., Viveros, H., Zhi, L. Negro-Vilar, A. 2007. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology 148, 363 373.
17. Noirez, P. Ferry, A. 2000. Effect of anabolic/androgenic steroids on myosin heavy chain expression in hindlimb muscles of male rats. Eur J Appl Physiol 81, 155 158.
18. Parfitt, A.M., Drezner, M.K., Glorieux, F.H., Kanis, J.A., Malluche, H., Meunier, P.J., Ott, S.M. Recker, R.R. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2, 595 610.
19. Pende, M. 2006. mTOR, Akt, S6 kinases and the control of skeletal muscle growth. Bull Cancer 93, E39 E43.
20. Shavlakadze, T. Grounds, M. 2006. Of bears, frogs, meat, mice and men: complexity of factors affecting skeletal muscle mass and fat. Bioessays 28, 994 1009.
21. Sims, N.A., Clement-Lacroix, P., Minet, D., Fraslon-Vanhulle, C., Gaillard-Kelly, M., Resche-Rigon, M. Baron, R. 2003. A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J Clin Invest 111, 1319 1327.
22. Solomon, A.M. Bouloux, P.M. 2006. Modifying muscle mass - the endocrine perspective. J Endocrinol 191, 349 360.
23. Srere, P.A. (1969). Citrate synthase. In : J.M. Lowenstein (ed.) Methods in Enzymology, Vol. 13, pp. 3 11, Academic Press, New York.
24. Taylor, J.A. Kandarian, S.C. 1994. Advantage of normalizing force production to myofibrillar protein in skeletal muscle cross-sectional area. J Appl Physiol 76, 974 978.
25. Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M.K., Bouillon, R. Ohlsson, C. 2004. Androgens and bone. Endocr Rev 25, 389 425.
26. Vignaud, A., Noirez, P., Besse, S., Rieu, M., Barritault, D. Ferry, A. 2003. Recovery of slow skeletal muscle after injury in the senescent rat. Exp Gerontol 38, 529 537.
27. Vignaud, A., Caruelle, J.P., Martelly, I. Ferry, A. 2006. Differential effects of post-natal development, animal strain and long term recovery on the restoration of neuromuscular function after neuromyotoxic injury in rat. Comp Biochem Physiol C Toxicol Pharmacol 143, 1 8.
28. Xu, T., Shen, Y., Pink, H., Triantafillou, J., Stimpson, S.A., Turnbull, P. Han, B. 2004. Phosphorylation of p70s6 kinase is implicated in androgen-induced levator ani muscle anabolism in castrated rats. J Steroid Biochem Mol Biol 92, 447 454.